Insights

Gathering insights about DiogenX…

Similar companies to DiogenX

DiogenX Tech Stack

DiogenX uses 8 technology products and services including MySQL, Shopify, Font Awesome, and more. Explore DiogenX's tech stack below.

MySQL
Database
Shopify
E-commerce
Font Awesome
Font Scripts
jQuery Migrate
Javascript Libraries
RSS
Miscellaneous
Revslider
Miscellaneous
Bootstrap
UI Frameworks
Slider Revolution
Widgets

Media & News

Diogenx hires dr. Klara as chief medical officer.
DiogenX appoints dr. Klara owen as chief medical officer.
Nov 12, 2024 | diogenx.com
Diogenx hired Klara Owen as Chief Medical Officer on Nov 12th '24.
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer.
Nov 12, 2024 | www.thepharmaletter.com
Diogenx hired Eleanor L. Ramos as independent member of board of directors on Sep 9th '24.
Marseille, France, September 9, 2024 - DiogenX, a biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Eleanor L. Ramos, MD, as an Independent Board Member.
Sep 09, 2024 | ala.associates
Diogenx hired Hélène Sicard as chief development officer on Jul 24th '24.
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announced the appointment of Hélène Sicard as chief development officer.
Jul 25, 2024 | www.thepharmaletter.com
Sunstone Capital invests into Diogenx.
Sunstone Life Science Ventures Fund IV invests in DiogenX, a biotech company developing a first-in-class regenerative treatment for type 1 diabetes.
Nov 01, 2023 | sunstone.eu
Boehringer Ingelheim International GmbH invested into Diogenx $29.7M on May 11th '23.
DiogenX, a regenerative medicine biotech company focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announced the successful completion of a €27.5 million ($30M) Series A financing round led by Boehringer Ingelheim Venture Fund (BIVF).
May 10, 2023 | diogenx.com
Diogenx hires David Evans as board of directors.
As part of the financing, David Evans joined DiogenX’s board of directors.
May 09, 2023 | www.explorebit.io

DiogenX's Email Address Formats

DiogenX uses at least 1 format(s):

DiogenX Email Formats	Example	Percentage
Last@diogenx.com	Doe@diogenx.com	46%
First.Last@diogenx.com	John.Doe@diogenx.com	4%
Last@diogenx.com	Doe@diogenx.com	46%
First.Last@diogenx.com	John.Doe@diogenx.com	4%

Frequently Asked Questions

Where is DiogenX's headquarters located?

DiogenX's main headquarters is located at Marseille, FR. The company has employees across 1 continents, including Europe.

What is DiogenX's official website and social media links?

DiogenX's official website is diogenx.com and has social profiles on LinkedIn.

How much revenue does DiogenX generate?

As of October 2024, DiogenX's annual revenue reached $750K.

What is DiogenX's SIC code NAICS code?

DiogenX's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does DiogenX have currently?

As of October 2024, DiogenX has approximately 15 employees across 1 continents, including Europe. Key team members include Chief Executive Officer - Co-Founder: B. C.Chief Medical Officer: K. O.Scientific Advisor And Co-Founder: P. C.. Explore DiogenX's employee directory with LeadIQ.

What industry does DiogenX belong to?

DiogenX operates in the Biotechnology Research industry.

What technology does DiogenX use?

DiogenX's tech stack includes MySQLShopifyFont AwesomejQuery MigrateRSSRevsliderBootstrapSlider Revolution.

What is DiogenX's email format?

DiogenX's email format typically follows the pattern of . Find more DiogenX email formats with LeadIQ.

How much funding has DiogenX raised to date?

As of October 2024, DiogenX has raised $37M in funding. The last funding round occurred on May 10, 2023 for $37M.

When was DiogenX founded?

DiogenX was founded in 2020.

DiogenX

Biotechnology ResearchMarseille, France11-50 Employees

DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world.
Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits.
DiogenX is headquartered in Marseille, with labs in Nice (France).

Company Overview

Headquarters: Marseille, FR
Website: diogenx.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2020
Employees: 11-50

Media & News

Funding & Financials

$37M
DiogenX has raised a total of $37M of funding over 2 rounds. Their latest funding round was raised on May 10, 2023 in the amount of $37M.
$10M
DiogenX's revenue is in the range of $10M

Funding & Financials

$37M
DiogenX has raised a total of $37M of funding over 2 rounds. Their latest funding round was raised on May 10, 2023 in the amount of $37M.
$10M
DiogenX's revenue is in the range of $10M

Company Leadership

B. C.
Chief Executive Officer - Co-Founder
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. O.
Chief Medical Officer
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. C.
Scientific Advisor And Co-Founder
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
G. P.
Chairman Of The Board
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. F.
Director Drug Development Sciences
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

C. T.
Senior Scientist
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. S.
Principal Scientist
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. A.
Member Of The Board Of Directors
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. E.
Board Member
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. N.
Biological Scientist
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DiogenX and Millions of Other Companies
Sign up for full access to DiogenX information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to DiogenX

Gaia Herbs

Now Foods

Nature's Way

Life Extension

Pure Encapsulations

Dr. Axe

Elysium Health

DiogenX Tech Stack

Media & News

Diogenx hires dr. Klara as chief medical officer.

Diogenx hired Klara Owen as Chief Medical Officer on Nov 12th '24.

Diogenx hired Eleanor L. Ramos as independent member of board of directors on Sep 9th '24.

Diogenx hired Hélène Sicard as chief development officer on Jul 24th '24.

Sunstone Capital invests into Diogenx.

Boehringer Ingelheim International GmbH invested into Diogenx $29.7M on May 11th '23.

Diogenx hires David Evans as board of directors.

DiogenX's Email Address Formats

Frequently Asked Questions

Where is DiogenX's headquarters located?

What is DiogenX's official website and social media links?

How much revenue does DiogenX generate?

What is DiogenX's SIC code NAICS code?

How many employees does DiogenX have currently?

What industry does DiogenX belong to?

What technology does DiogenX use?

What is DiogenX's email format?

How much funding has DiogenX raised to date?

When was DiogenX founded?

DiogenX

Company Overview

Media & News

Diogenx hires dr. Klara as chief medical officer.

Diogenx hired Klara Owen as Chief Medical Officer on Nov 12th '24.

Diogenx hired Eleanor L. Ramos as independent member of board of directors on Sep 9th '24.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?